新冠病毒疫苗对Omicron变异的疗效

Biomedical research and clinical reviews Pub Date : 2022-03-24 DOI:10.31579/2692-9406/109

Sadique Hussain

{"title":"新冠病毒疫苗对Omicron变异的疗效","authors":"Sadique Hussain","doi":"10.31579/2692-9406/109","DOIUrl":null,"url":null,"abstract":"The introduction of coronavirus (CoV) shocked our planet in December 2019, resulting in over five million deaths worldwide over the previous two years [1]. Physical and social separation is required as a precautionary step for this infectious and transmissible pandemic. There are several mutant variations of the original SARS-CoV-2. Because of its striking similarities to SARS-CoV, the new coronavirus was first termed SARS-CoV-2 (2019-nCoV), but was later designated Coronavirus Disease-19, or COVID-19","PeriodicalId":72392,"journal":{"name":"Biomedical research and clinical reviews","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Covid-19 Vaccine Efficacy on Omicron Variant\",\"authors\":\"Sadique Hussain\",\"doi\":\"10.31579/2692-9406/109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The introduction of coronavirus (CoV) shocked our planet in December 2019, resulting in over five million deaths worldwide over the previous two years [1]. Physical and social separation is required as a precautionary step for this infectious and transmissible pandemic. There are several mutant variations of the original SARS-CoV-2. Because of its striking similarities to SARS-CoV, the new coronavirus was first termed SARS-CoV-2 (2019-nCoV), but was later designated Coronavirus Disease-19, or COVID-19\",\"PeriodicalId\":72392,\"journal\":{\"name\":\"Biomedical research and clinical reviews\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedical research and clinical reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31579/2692-9406/109\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical research and clinical reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31579/2692-9406/109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

2019年12月，冠状病毒（CoV）的引入震惊了我们的星球，在过去两年中，全球有500多万人死亡[1]。身体和社会隔离是应对这种传染性和可传播性流行病的预防措施。原始严重急性呼吸系统综合征冠状病毒2型有几种突变变体。由于其与SARS-CoV惊人的相似性，新型冠状病毒最初被称为SARS-CoV-2（2019-nCoV），但后来被命名为冠状病毒病-19或新冠肺炎

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Covid-19 Vaccine Efficacy on Omicron Variant

The introduction of coronavirus (CoV) shocked our planet in December 2019, resulting in over five million deaths worldwide over the previous two years [1]. Physical and social separation is required as a precautionary step for this infectious and transmissible pandemic. There are several mutant variations of the original SARS-CoV-2. Because of its striking similarities to SARS-CoV, the new coronavirus was first termed SARS-CoV-2 (2019-nCoV), but was later designated Coronavirus Disease-19, or COVID-19

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Biomedical research and clinical reviews

自引率

0.00%

发文量